Decrease in autoantibody titres during long-term treatment of scleroderma with rituximab: a promising surveillance marker of therapy?. (2nd November 2015) - Moazedi-Fuerst, FC; Kielhauser, SM; Hermann, J; Meilinger, M; Demel, U; Stradner, MH; Graninger, WB